Associated Papers
Impact of the melanocortin-4 receptor agonist setmelanotide on MASLD and kidney function in Bardet-Biedl syndrome.
Hühne T et al.
The Journal of Clinical Endocrinology and Metabolism, 2025
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.
Collet TH et al.
Molecular Metabolism, 2017
29031731 (PubMed )
Supplement: mmc2.xlsx › Table_S2
Increased constraints on MC4R during primate and human evolution.
Hughes DA et al.
Human Genetics, 2009
Select a paper to view details